Category Innovation/ R&D

USTR Froman Presses India On IPR Regime

"Nearly one-third of all Silicon Valley start-ups have an Indian-American co-founder," United States Trade Representative Michael Froman said in remarks on India today. The country of India is also innovating, but it must do more to have and enforce a world-class intellectual property rights regime, he said.

Hard Bargaining In IP Chapter Of Trans-Pacific Partnership, Trade Ministers Say

Intellectual property is still one of the most complex and challenging areas of the Trans-Pacific Partnership (TPP), as some countries are holding fast to high levels of IP protection to promote innovation and creativity, while others continue to seek a greater emphasis on access to ideas. This appears to be the message of today's statement from trade ministers of countries negotiating the TPP.

Global Differences On Patents Lead WIPO Patent Law Committee To Stumble On Future Work

Once again, differences over the role of a World Intellectual Property Organization committee last week came in the way of consensus and prevented delegates from agreeing on future work. At the heart of the discontent was the perceived imbalance of the proposed programme of work, which some said disregarded the interests of developing countries. A speaker for the African region gave a striking speech on the Ebola crisis as an example of the failure of the patent system.

Expect Strong IP Push From Global Pharma Industry Next Year; WHO Prescribes Dose Of Reality

NEW YORK - Strong intellectual property rights will be a top priority for the pharmaceutical industry internationally in the coming year and arguments over IPRs versus medicines access are false, a top representative said at a high-level industry event this week. But views at the event differed on expectations of industry in light of the Ebola crisis, hepatitis C drug costs or other medicines access questions.

WTO, WHO, WIPO Examine IPRs And Middle-Income Countries

The current income-based grouping of countries needs to be changed or access to medicines in middle-income countries will worsen, several speakers said yesterday at a joint meeting between three international organisations on health, trade, and intellectual property. But middle-income countries should step up their engagement in organisations such as the World Health Organization, according to WHO and civil society.